Acumen Pharmaceuticals (ABOS) Times Interest Earned (2020 - 2026)
Acumen Pharmaceuticals (ABOS) reported Times Interest Earned of -$19.78 for Q1 2026, up 33.36% on a YoY basis from -$14.84 in Q1 2025, and up 14.66% sequentially from -$23.18 in Q4 2025.
Acumen Pharmaceuticals (ABOS) Times Interest Earned (2020 - 2026) Analysis & Trends
Acumen Pharmaceuticals (ABOS) has 7 years of Times Interest Earned data on file, last reported at -$19.78 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 33.36% year-over-year to -$19.78; the trailing twelve-month figure through Mar 2026 stood at -$26.84 (up 36.49% YoY), and the FY2025 full-year result was -$1.45, up 28.33% from the prior year.
- Times Interest Earned grew to -$19.78 in Q1 2026, from -$23.18 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $682.71 in Q4 2024 to a low of -$336.95 in Q2 2023.
- A 5-year average of -$26.33 and a median of -$24.55 in 2024 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned tumbled 40356.01% in 2023 and surged 724.13% in 2024, its largest moves.
- Tracing ABOS's Times Interest Earned over 5 years: stood at $124.98 in 2022, then slumped by 187.52% to -$109.38 in 2023, then surged by 724.13% to $682.71 in 2024, then plunged by 103.4% to -$23.18 in 2025, then increased by 14.66% to -$19.78 in 2026.
- Business Quant data shows ABOS's Times Interest Earned at -$19.78 in Q1 2026, -$23.18 in Q4 2025, and -$24.82 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Acumen Pharmaceuticals | 140.98 Mn | 140.98 Mn | - | -19.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.78 |
| Dec 31, 2025 | -23.18 |
| Sep 30, 2025 | -24.82 |
| Jun 30, 2025 | -39.91 |
| Mar 31, 2025 | -29.69 |
| Dec 31, 2024 | 682.71 |
| Sep 30, 2024 | -31.42 |
| Jun 30, 2024 | -24.28 |
| Mar 31, 2024 | -17.77 |
| Dec 31, 2023 | -109.38 |
| Jun 30, 2023 | -336.95 |
| Mar 31, 2023 | -328.38 |
| Dec 31, 2022 | 124.98 |
| Sep 30, 2022 | -0.29 |
| Jun 30, 2022 | -0.83 |
| Mar 31, 2022 | -242.26 |
| Dec 31, 2021 | 365.87 |
| Sep 30, 2021 | -171.09 |
| Jun 30, 2021 | -0.07 |
| Dec 31, 2020 | -0.17 |